Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:21:19.529Z.
Calculation as of: 2026-10-06T17:21:19.529Z.
Quote observation: 2026-10-06T17:18:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$43.87M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.17M
Operating Cash Flow Yield
12.10%
TTM Avg
4.34%
3Y Avg
2.96%
5Y Avg
2.96%
Market Cap
$45.17M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.63M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$42.11M
Operating Cash Flow Yield
2.61%
TTM Avg
2.14%
3Y Avg
3.12%
5Y Avg
3.12%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.05M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.87M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.70M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.60M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.17M | 12.10% | 4.34% | 2.96% | 2.96% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.17M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $42.63M | N/A | 11.87% | 9.02% | 6.85% |
| Precipio, Inc. (PRPO)vs › | $42.11M | 2.61% | 2.14% | 3.12% | 3.12% |
| Instil Bio, Inc. (TIL)vs › | $46.97M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.14M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
